研究简报

新型二茂铁基1,2,4-三唑Mannich碱的合成及其Cdc25B抑制活性

  • 张成路 ,
  • 王雪 ,
  • 国阳 ,
  • 吴一非 ,
  • 高丽娜 ,
  • 孙丽杰 ,
  • 柴金华 ,
  • 朱长安
展开
  • 辽宁省生物与制药重点实验室 辽宁师范大学化学化工学院 大连 116029

收稿日期: 2014-05-10

  修回日期: 2014-07-14

  网络出版日期: 2014-07-17

基金资助

辽宁省教育厅科学技术(No.2009A426)资助项目.

Synthesis and Inhibitory Activity of Novel Ferrocenyl 1,2,4-Triazole Mannich Bases

  • Zhang Chenglu ,
  • Wang Xue ,
  • Guo Yang ,
  • Wu Yifei ,
  • Gao Lina ,
  • Sun Lijie ,
  • Chai Jinhua ,
  • Zhu Chang'an
Expand
  • Liaoning Provincial Key Laboratory of Biotechnology and Drug Discovery, College of Chemistry and Chemical Engineering, Liaoning Normal University, Dalian 116029

Received date: 2014-05-10

  Revised date: 2014-07-14

  Online published: 2014-07-17

Supported by

Project supported by the Technology Research Program of Liaoning Provincial Department of Education (No.2009A426).

摘要

以5种二茂铁基三唑席夫碱为原料, 分别与吗啉、哌嗪和N-甲基哌嗪等进行曼尼希反应, 首次设计合成了15个新型3-二茂铁基-1,2,4-均三唑曼尼希碱(3a~3e4a~4e5a~5e). 通过IR、1H NMR和HRMS等测试方法对目标化合物结构进行了表征, 并对代表目标化合物3b进行X-ray单晶衍射测试. 研究了目标产物对Cdc25B的抑制活性, 结果发现, 13个目标化合物表现出良好的抑制活性, 其中3c4a5b5c5e等5个化合物的IC50值小于阳性参照物正矾酸钠(1.86±0.24 μg·mL-1), 分别为0.91±0.18、0.62±0.13、1.10±0.33、0.44±0.04和0.67±0.13 μg·mL-1, 对比PTP1B抑制活性筛选结果, 目标化合物对Cdc25B有选择性的抑制作用, 可以作为潜在的Cdc25B抑制剂.

本文引用格式

张成路 , 王雪 , 国阳 , 吴一非 , 高丽娜 , 孙丽杰 , 柴金华 , 朱长安 . 新型二茂铁基1,2,4-三唑Mannich碱的合成及其Cdc25B抑制活性[J]. 有机化学, 2014 , 34(11) : 2331 -2337 . DOI: 10.6023/cjoc201405015

Abstract

15 novel 3-ferrocenyl-1,2,4-triazole Mannich bases (3a~3e, 4a~4e and 5a~5e) were designed and synthesized for the first time by Mannich reaction from five 3-ferrocenyl-1,2,4-triazole Schiff bases, which reacted with morpholine, 1-methylpiperazine and piperazine, respectively. The structures of 3, 4 and 5 were characterized by IR, 1H NMR and HRMS. The X-ray single crystal diffraction of 3b was obtained. The results showed that the target compounds were successfully synthesized. The target products were evaluated for their Cdc25B inhibitory activities. The test results indicated that 13 of 15 Mannich bases exhibited good inhibitory activity, wherein IC50 values of 3c, 4a, 5b, 5c and 5e were lower than the positive control compound Na3VO4 (1.86±0.24 μg·mL-1) with 0.91±0.18, 0.62±0.13, 1.10±0.33, 0.44±0.04 and 0.67±0.13 μg·mL-1, respectively. Compared with PTP1B inhibition activity results, the target products have a selective inhibitory effect on Cdc25B.

参考文献

[1] Tsuchiya, A.; Hirai, G.; Koyama, Y.; Oonuma, K.; Otani, Y.; Osada, H.; Sodeoka, M. Med. Chem. Lett. 2012, 3, 294.
[2] Lavecchia, A.; Giovanni, C. D.; Pesapane, A.; Montuori, N.; Ragno, P.; Martucci, N. M.; Masullo, M.; Vendittis, E. D.; Novellino, E. J. Med. Chem. 2012, 55, 4142.
[3] Zhang, J.; Ji, F. J.; Gu, Y.; Zhang, X. Y.; Qiao, S. X. Pharmacol. Rep. 2014, 66, 515.
[4] Park, Y. H.; Jeon, Y. H.; Kim, I. Y. Biochim. Biophys. Acta, Mol. Cell Res. 2012, 1823, 2217.
[5] Boutros, R.; Lobjois, V.; Ducommun, B. Nat. Rev. Cancer 2007, 7, 495.
[6] Sarkis, M.; Tran, D. N.; Kolb, S.; Miteva, M. A.; Villoutreix, B. O.; Garbay, C.; Braud, E. Bioorg. Med. Chem. Lett. 2012, 22, 7345.
[7] Lavecchia, A.; Giovanni, C. D.; Pesapane, A.; Montuori, N.; Ragno, P.; Martucci, N. M.; Masullo, M.; Vendittis, E. D.; Novellino, E. J. Med. Chem. 2012, 55, 4142.
[8] Kim, K. R.; Kwon, J. L.; Kim, J. S.; No, Z.; Kim, H. R.; Cheon, H. G. Eur. J. Pharmacol. 2005, 528, 37.
[9] Bhattacharjee, H.; Sheng, J.; Ajees, A. A.; Mukhopadhyay, R.; Rosen, B. P. Biochemistry 2010, 49, 802.
[10] Yu, H. B.; Shao, L.; Fang, J. X. J. Organomet. Chem. 2007, 692, 991.
[11] Huang, X. F.; Wang, L. Z.; Tang, L.; Lu, Y. X.; Wang, F.; Song, G. Q.; Ruan, B. F. J. Organomet. Chem. 2014, 749, 157.
[12] Kerstin, S.; Tim, K.; Yusuf, T. Bioorg. Med. Chem. 2009, 17, 7186.
[13] Ram, S. U.; Jaya, K. V.; Ramakant, A. K. Eur. J. Med. Chem. 2010, 45, 1854.
[14] Guo, H.; Zhang, G. L.; Zhang, T. Eur. J. Med. Chem. 2011, 46, 3662.
[15] Ji, D.; Lu, J. R.; Xin, C. W.; Peng, C. Y.; Mu, J. B.; Li, J. F. Chin. J. Org. Chem. 2013, 33, 1062 (in Chinese).(戢丹, 卢俊瑞, 辛春伟, 彭春勇, 穆江蓓, 李建发, 有机化学, 2013, 33, 1062.)
[16] Zhu, C. A.; Wu, F. Y. Wang, X; Gao, L. N.; Weng, Q. F.; Shi, L.; Zhang, C. L. Chin. J. Appl. Chem. 2014, 31, 455 (in Chinese).(朱长安, 武飞宇, 王雪, 高丽娜, 翁前锋, 石丽, 张成路, 应用化学, 2014, 31, 455.)
[17] Wang, B. L.; Liu, X. H.; Zhang, X. L.; Zhang, J. F.; Song, H. B.; Li, Z. M. Chem. Biol. Drug Des. 2011, 78, 42.
[18] Sun, L. P.; Shen, Q.; Piao, H. H.; Ma, W. P.; Gao, L. X.; Zhang, W.; Nan, F. J.; Li, J.; Piao, H. R. Eur. J. Med. Chem. 2011, 46, 3630.
[19] Shi, L.; Yu, H. P.; Zhou, Y. Y.; Du, J. Q.; Shen, Q.; Li, J. Y.; Li, J. Acta. Pharmacol. Sin. 2008, 29, 278.
[20] Huang, W. G.; Jiang, Y. Y.; Li, Q.; Li, J.; Li, J. Y.; Lu, W.; Cai, J. C. Tetrahedron 2005, 61, 1863.
[21] Li, Q. Z.; Song, B. A.; Cai, X. J.; Zheng, Y. G.; Guo, Q. Q. Chin. J. Org. Chem. 2010, 30, 569 (in Chinese).(李黔柱, 宋宝安, 蔡学建, 郑玉国, 郭晴晴, 有机化学, 2010, 30, 569.)
[22] Yan, L.; Liu, F. W.; Liu, H. M. Chin. J. Org. Chem. 2011, 31, 1639 (in Chinese).(严琳, 刘丰五, 刘宏民, 有机化学, 2011, 31, 1639.)
[23] Dai, H.; Liu, J. B.; Miao, W. K.; Wu, S. S.; Qin, X.; Zhang, X.; Wang, T. T.; Fang, J. X. Chin. J. Org. Chem. 2011, 31, 1662 (in Chinese).(戴红, 刘建兵, 苗文科, 吴珊珊, 秦雪, 张欣, 王婷婷, 方建新, 有机化学, 2011, 31, 1662.)
[24] Peng, C. Y; Lu, J. R.; Xin, C. W.; Li, J. F; Ji, D.; Bao, X. R. Chem. J. Chin. Univ. 2013, 34, 1394 (in Chinese).(彭春勇, 卢俊瑞, 辛春伟, 李建发, 戢丹, 鲍秀荣, 高等学校化学学报, 2013, 34, 1394.)

文章导航

/